Elecsys Tacrolimus— 510(k) K173857

Substantially Equivalent

Roche Diagnostics

FDA 510(k) clearance K173857 for Elecsys Tacrolimus, Substantially Equivalent on 2018-11-06. Applicant: Roche Diagnostics.

Clearance details

Applicant
Roche Diagnostics
Product code
Code MLM
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Indianapolis, IN, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.